Designing an Accurate Benchtop Characterization Device: An Acoustic Measurement Platform for Localizing and Implementing Therapeutic Ultrasound Devices and Equipment (Amplitude)

Ruixing Liang, Max J. Kerensky, Eli Curry, Griffin Mess, Rasika Thombre, Serene Kamal, Fariba Aghabaglou, Richard Mejia, Francisco Chavez, Kyle Morrison, Nitish Thakor, N. Theodore, A. Manbachi
{"title":"Designing an Accurate Benchtop Characterization Device: An Acoustic Measurement Platform for Localizing and Implementing Therapeutic Ultrasound Devices and Equipment (Amplitude)","authors":"Ruixing Liang, Max J. Kerensky, Eli Curry, Griffin Mess, Rasika Thombre, Serene Kamal, Fariba Aghabaglou, Richard Mejia, Francisco Chavez, Kyle Morrison, Nitish Thakor, N. Theodore, A. Manbachi","doi":"10.1115/dmd2022-1046","DOIUrl":null,"url":null,"abstract":"\n Focused ultrasound (FUS) is becoming widely researched for medical therapies due to its high penetration depth, spatial resolution, and affordability. Applications of FUS range from high intensity focused ultrasound (HIFU) for the ablation of cancerous tumors to low intensity focused ultrasound (LIFU) for the treatment of neurological conditions like essential tremors. A key step in developing these treatments and their corresponding FUS devices is characterizing the emitted ultrasound from the proposed transducer. However, a bottleneck exists at this verification and validation stage; current characterization techniques lack the robustness of reliably recording below a 5μm resolution. This level of accuracy is needed to adequately design devices which can target cells like astrocytes or other desired target tissues at this scale. Our Acoustic Measurement Platform for Localizing and Implementing Therapeutic Ultrasound Devices and Equipment (AMPLITUDE) is a solution which enables engineers, scientists, and clinicians to confidently characterize their equipment in a benchtop setting. It achieves this resolution by utilizing an all-in-one water conditioning unit, linear stepper motors with a theoretical step size of 1 μm and a 1% standard deviation on repetitive experiments, as well as signal processing techniques. This system can be used throughout the product timeline including prototyping, verifying efficacy, FDA testing, and routine check-ups during clinical use.","PeriodicalId":236105,"journal":{"name":"2022 Design of Medical Devices Conference","volume":"119 1","pages":"0"},"PeriodicalIF":0.0000,"publicationDate":"2022-04-11","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"2022 Design of Medical Devices Conference","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1115/dmd2022-1046","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0

Abstract

Focused ultrasound (FUS) is becoming widely researched for medical therapies due to its high penetration depth, spatial resolution, and affordability. Applications of FUS range from high intensity focused ultrasound (HIFU) for the ablation of cancerous tumors to low intensity focused ultrasound (LIFU) for the treatment of neurological conditions like essential tremors. A key step in developing these treatments and their corresponding FUS devices is characterizing the emitted ultrasound from the proposed transducer. However, a bottleneck exists at this verification and validation stage; current characterization techniques lack the robustness of reliably recording below a 5μm resolution. This level of accuracy is needed to adequately design devices which can target cells like astrocytes or other desired target tissues at this scale. Our Acoustic Measurement Platform for Localizing and Implementing Therapeutic Ultrasound Devices and Equipment (AMPLITUDE) is a solution which enables engineers, scientists, and clinicians to confidently characterize their equipment in a benchtop setting. It achieves this resolution by utilizing an all-in-one water conditioning unit, linear stepper motors with a theoretical step size of 1 μm and a 1% standard deviation on repetitive experiments, as well as signal processing techniques. This system can be used throughout the product timeline including prototyping, verifying efficacy, FDA testing, and routine check-ups during clinical use.
查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
设计一个精确的台式表征设备:用于定位和实施治疗超声设备和设备的声学测量平台(振幅)
聚焦超声(FUS)因其高穿透深度、空间分辨率和可负担性而在医学治疗中得到广泛研究。FUS的应用范围从用于癌性肿瘤消融的高强度聚焦超声(HIFU)到用于治疗原发性震颤等神经系统疾病的低强度聚焦超声(LIFU)。开发这些治疗方法及其相应的FUS装置的关键步骤是表征所提出的换能器发射的超声波。然而,在这个验证和确认阶段存在瓶颈;目前的表征技术缺乏在5μm分辨率以下可靠记录的鲁棒性。这种精度水平是需要充分设计的设备,可以靶向细胞,如星形胶质细胞或其他期望的目标组织在这个规模。我们用于定位和实施治疗超声设备和设备的声学测量平台(振幅)是一种解决方案,使工程师,科学家和临床医生能够在台式设置中自信地表征他们的设备。它通过使用一体化水处理单元、理论步长为1 μm、重复实验标准偏差为1%的线性步进电机以及信号处理技术来实现这一分辨率。该系统可以在整个产品时间线中使用,包括原型设计,验证功效,FDA测试和临床使用期间的常规检查。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
自引率
0.00%
发文量
0
期刊最新文献
Communicating Cybersecurity and Privacy Design Attributes through Privacy Labeling of Consumer Electronic Medical Devices A Novel Tool for Auricle Retraction During Closure of Post-Auricular Incisions Development and Characterization of Biostable Hydrogel Robotic Actuators for Implantable Devices: Tendon Actuated Gelatin Non-Invasive Diagnosis of Deep Vein Thrombosis to Expedite Treatment and Prevent Pulmonary Embolism During Gestation Development of an Epicardial Mapping Tank for Noninvasive Electrical Mapping of Ex Vivo Large Mammalian Hearts
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1